
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation
Chia-Chun Chen, Wendy Tran, Kai Song, et al.
Cancer Cell (2023) Vol. 41, Iss. 12, pp. 2066-2082.e9
Open Access | Times Cited: 32
Chia-Chun Chen, Wendy Tran, Kai Song, et al.
Cancer Cell (2023) Vol. 41, Iss. 12, pp. 2066-2082.e9
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Cancer plasticity in therapy resistance: Mechanisms and novel strategies
Xing Niu, Wenjing Liu, Zhang Yinling, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101114-101114
Closed Access | Times Cited: 15
Xing Niu, Wenjing Liu, Zhang Yinling, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101114-101114
Closed Access | Times Cited: 15
Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies
Tongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1336-1351.e9
Open Access | Times Cited: 11
Tongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1336-1351.e9
Open Access | Times Cited: 11
The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1
Rodrigo Romero, Tinyi Chu, Tania J. González-Robles, et al.
Nature Cancer (2024) Vol. 5, Iss. 11, pp. 1641-1659
Open Access | Times Cited: 9
Rodrigo Romero, Tinyi Chu, Tania J. González-Robles, et al.
Nature Cancer (2024) Vol. 5, Iss. 11, pp. 1641-1659
Open Access | Times Cited: 9
Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators
Zhanyu Wang, Chengming Liu, Sufei Zheng, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 1106-1125.e8
Closed Access | Times Cited: 8
Zhanyu Wang, Chengming Liu, Sufei Zheng, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 1106-1125.e8
Closed Access | Times Cited: 8
Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer
John B. Finlay, Abbie S. Ireland, Sarah B. Hawgood, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 1086-1105.e13
Open Access | Times Cited: 5
John B. Finlay, Abbie S. Ireland, Sarah B. Hawgood, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 1086-1105.e13
Open Access | Times Cited: 5
Single-cell RNA sequencing highlights the unique tumor microenvironment of small cell neuroendocrine cervical carcinoma
Tianyou Wang, Li Zhang, Song Mei, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Tianyou Wang, Li Zhang, Song Mei, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Neuroendocrine Transformation as a Mechanism of Resistance to Targeted Lung Cancer Therapies: Emerging Mechanisms and Their Therapeutic Implications
Asim Joshi, Neeru Bhaskar, Joel D. Pearson
Cancers (2025) Vol. 17, Iss. 2, pp. 260-260
Open Access
Asim Joshi, Neeru Bhaskar, Joel D. Pearson
Cancers (2025) Vol. 17, Iss. 2, pp. 260-260
Open Access
Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors
Xiong Zhang, Yatian Yang, Hongye Zou, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Xiong Zhang, Yatian Yang, Hongye Zou, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolution
Kira Furlano, Tina Keshavarzian, Nadine Biernath, et al.
International Journal of Cancer (2025)
Open Access
Kira Furlano, Tina Keshavarzian, Nadine Biernath, et al.
International Journal of Cancer (2025)
Open Access
USP13: A therapeutic target for combating tumorigenesis and antitumor therapy resistance
Lina Yi, Akezhouli Shahatiaili, Lin Zhang, et al.
International Journal of Biological Macromolecules (2025), pp. 140608-140608
Closed Access
Lina Yi, Akezhouli Shahatiaili, Lin Zhang, et al.
International Journal of Biological Macromolecules (2025), pp. 140608-140608
Closed Access
Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer
Xiaolin Zhu, Chien‐Kuang Cornelia Ding, Rahul Aggarwal
Current Oncology Reports (2025)
Closed Access
Xiaolin Zhu, Chien‐Kuang Cornelia Ding, Rahul Aggarwal
Current Oncology Reports (2025)
Closed Access
Epigenetic regulation of reprogramming and pluripotency: insights from histone modifications and their implications for cancer stem cell therapies
Wooli Bae, Eun A., Myon‐Hee Lee
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Wooli Bae, Eun A., Myon‐Hee Lee
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Challenges of small cell lung cancer heterogeneity and phenotypic plasticity
Kathryn Simpson, Dominic G. Rothwell, Fiona Blackhall, et al.
Nature reviews. Cancer (2025)
Closed Access
Kathryn Simpson, Dominic G. Rothwell, Fiona Blackhall, et al.
Nature reviews. Cancer (2025)
Closed Access
Neuroendocrine Prostate Cancer: An Overlooked Identity?
Nastasiia Artamonova, Isabel Heidegger
IntechOpen eBooks (2025)
Closed Access
Nastasiia Artamonova, Isabel Heidegger
IntechOpen eBooks (2025)
Closed Access
CUL4B regulates thyroid cancer differentiation and treatment sensitivity by ubiquitinating ARID1A
Haiyan Gu, Bo Han, Jing Hu, et al.
Translational Oncology (2025) Vol. 56, pp. 102389-102389
Closed Access
Haiyan Gu, Bo Han, Jing Hu, et al.
Translational Oncology (2025) Vol. 56, pp. 102389-102389
Closed Access
Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven Malignancies
Tongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Tongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
PGC-1α drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased mitochondrial capacity
Grigor Varuzhanyan, Chia‐Chun Chen, Jack Freeland, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Grigor Varuzhanyan, Chia‐Chun Chen, Jack Freeland, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Mechanisms governing lineage plasticity and metabolic reprogramming in cancer
Lillian M. Perez, Smrruthi V. Venugopal, Anna St Martin, et al.
Trends in cancer (2024)
Open Access | Times Cited: 2
Lillian M. Perez, Smrruthi V. Venugopal, Anna St Martin, et al.
Trends in cancer (2024)
Open Access | Times Cited: 2
Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer
Abbie S. Ireland, Sarah B. Hawgood, Dong Xie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Abbie S. Ireland, Sarah B. Hawgood, Dong Xie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Harnessing machine learning and multi-omics to explore tumor evolutionary characteristics and the role of AMOTL1 in prostate cancer
Weian Zhu, Jianjie Wu, Wenjie Lai, et al.
International Journal of Biological Macromolecules (2024) Vol. 286, pp. 138402-138402
Closed Access | Times Cited: 2
Weian Zhu, Jianjie Wu, Wenjie Lai, et al.
International Journal of Biological Macromolecules (2024) Vol. 286, pp. 138402-138402
Closed Access | Times Cited: 2
BET inhibitors as a therapeutic intervention in gastrointestinal gene signature-positive castration-resistant prostate cancer
Shipra Shukla, Dan Li, Holly M. Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Shipra Shukla, Dan Li, Holly M. Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Mechanism exploration and model construction for small cell transformation in EGFR-mutant lung adenocarcinomas
Yan Li, Tongji Xie, Shouzheng Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Yan Li, Tongji Xie, Shouzheng Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Spatial analyses revealed S100P + TFF1 + tumor cells in spread through air spaces samples correlated with undesirable therapy response in non-small cell lung cancer
Guangyu Fan, Tongji Xie, Mengwei Yang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Guangyu Fan, Tongji Xie, Mengwei Yang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Meta-analyses of mouse and human prostate single-cell transcriptomes reveal widespread epithelial plasticity in tissue regression, regeneration, and cancer
Luis Aparicio, Laura Crowley, John R. Christin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Luis Aparicio, Laura Crowley, John R. Christin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Understanding the molecular regulators of neuroendocrine prostate cancer
Sreyashi Bhattacharya, Avery Stillahn, Kaitlin Smith, et al.
Advances in cancer research (2024), pp. 403-429
Closed Access
Sreyashi Bhattacharya, Avery Stillahn, Kaitlin Smith, et al.
Advances in cancer research (2024), pp. 403-429
Closed Access